Vucruz says acute respiratory syndrome cases are up 135% in Brazil

Rio – cases severe acute respiratory syndrome (SARS) It rose 135% in Brazil in the past three weeks compared to the same period in November, from 5,600 cases to 13,000, it reported Oswaldo Cruz Foundation (Vuecruz). For more than a month, the agency has not released data on the disease due to a “blackout” in the ministry’s information system. COVID-19 in Brazil. Variable dispersion omicron He filled health clinics and caused a tsunami of infected people in the country.

according to InfoFlu . Bulletin From the foundation, released this Saturday, 15, the speed with which covid-19 is spreading among the Brazilian population has grown, per week, from 4% to 30% since November. Vucruz reported that the escalation of SRAG occurred in all 10-year age groups, from the end of November and the beginning of December until this month.

“Laboratory data indicate that this increase was a result of the influenza pandemic and the resumption of growth in cases of COVID-19,” Vucruz told. Growth was recorded in all 10-year age groups from late November and early December to January. The same did not happen in the 0-9 age group, which showed at the end of December the pollution growth that had been going on since October 2021 had stopped.

According to the researcher in charge of InfoGripe, Marcelo Gomez, in the age group between 10 and 19, it is possible that the country has already reached levels similar to those recorded in the March and May 2021 peaks. For children aged 0 to 9 years, the results indicate Laboratory associated with these cases to predominance Respiratory syncytial virus (RSV), with an increase in influenza A cases at the end of November and throughout December 2021. The vaccination of children between the ages of 5 and 11 only began this Friday, 14, in Brazil, about a month after the approval of the Pfizer vaccine for this group.

In all age groups, there is a significant increase in cases associated with the virus. Effect A (ache) At the end of November and throughout December, having even surpassed covid-19 records in some of these weeks. However, data for the end of December and the first week of January indicate a resumption of Covid-19 dominance.

Except for Roraima and Rio de Janeiro, all states have a sign of growth in acute respiratory syndrome cases in the long-term trend, and all of these have an indication of a strong level (probability greater than 95%): Acre, Alagoas, Amazonas, Amapá, Bahia, Ceará, Federal District, Espírito Santo , Goiás, Maranhão, Mato Grosso, Mato Grosso do Sul, Minas Gerais, Barra, Paraíba, Pernambuco, Piauí, Parana, Rio Grande do Norte, Rio Grande do Sul, Rondonia, Santa Catarina, Sao Paulo, Sergipe and Tocantins.

Only among these countries Amazonas and Rondônia Signs of stability appear in the short-term trend. All other signs show signs of growth, this sign is moderate (greater than 75% probability) in Amapá, Para and Piauí, and strong in all other signs. In Rio de Janeiro, the trend is short-term transitory growth, although the long-term trend is in a stable position. The researcher notes that the scenario of an increase in serious cases of influenza and covid-19, before the holiday season, indicates that such events may represent a significant risk to the population, especially in events with many people.

“This fact makes it necessary to resume measures to raise awareness of the population and reduce risks to limit the impact throughout the beginning of 2022. This data also illustrates the importance of cancellation of major events by authorities in different locations, even though the notification data were presenting problems in their disclosure,” he said. Gomez.

Laboratory data by union units trace a very similar picture in almost all states, “It is clear that the beginning of the influenza A epidemic in Rio de Janeiro spread rapidly to the rest of the country,” comments Gomez. He concludes by drawing attention to the fact that “there is always a delay between identification of cases and the laboratory result and the introduction of the result in Influenza Epidemiological Surveillance System (Sivep-Gripe).